Comparative Pharmacology
Head-to-head clinical analysis: XYZAL versus ZYRTEC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: XYZAL versus ZYRTEC.
XYZAL vs ZYRTEC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Levocetirizine is a selective histamine H1-receptor antagonist; it inhibits the histamine-mediated responses in allergic conditions.
Selective histamine H1-receptor antagonist; inhibits histamine release from mast cells and basophils.
5 mg orally once daily in the evening.
5-10 mg orally once daily; maximum 10 mg/day.
None Documented
None Documented
Terminal elimination half-life is approximately 7 hours in healthy adults; prolonged to 8–11 hours in elderly and in renal impairment.
Terminal elimination half-life is approximately 8-11 hours in healthy adults, prolonged in renal impairment (e.g., up to 20 hours in moderate renal failure).
Approximately 84% of a dose is excreted renally as unchanged drug; 12% in feces via biliary elimination.
Cetirizine is primarily excreted unchanged in urine (approximately 70% renal elimination) and feces (about 10%).
Category C
Category C
Antihistamine
Antihistamine